Table 1.
Participant characteristics from cross‐sectional study
| Men | Women | ALL | n Total | |
|---|---|---|---|---|
| Age | 44.4 ± 4.8 (27, 19–84) | 48.5 ± 3.6 (30, 18–76) | 46.5 ± 3.0 | 57 |
| Mass (kg) | 81.9 ± 2.3 (27, 64.5–102.7) | 70.3 ± 2.1 (30, 55–91.4)a | 75.8 ± 1.7 | 57 |
| BMI (kg/m2) | 25.8 ± 0.8 (27, 20–32) | 26.2 ± 0.7 (30, 19–31) | 26 ± 0.5 | 57 |
| Body fat (%) | 23.3 ± 1.9 (27, 14–39) | 38.9 ± 1.5 (30, 16–53)a | 31.5 ± 1.6 | 57 |
| Trunk fat (%) | 28.0 ± 2.4 (24, 15.9–45.1) | 39.8 ± 1.7 (30, 14.3–54.8)a | 34.6 ± 1.6 | 54 |
| Lean body mass (kg) | 58.2 ± 1.1 (27, 48.3–68) | 39.6 ± 1.0 (30, 31.7–47)a | 48.2 ± 1.4 | 57 |
| Waist‐to‐hip ratio | 0.87 ± 0.02 (26, 0.76–1.04) | 0.76 ± 0.01 (29, 0.66–0.92)a | 0.81 ± 0.01 | 55 |
| VO2peak (mL/kg/min) | 34.4 ± 2.4 (26, 12.6–58.7) | 25.0 ± 1.4 (30, 12.6–37.9)a | 29.3 ± 1.5 | 56 |
| Fasting plasma glucose (mg/dL) | 89.0 ± 1.5 (27, 73–105) | 88.5 ± 1.9 (30, 71–118) | 88.7 ± 1.2 | 57 |
| Fasting plasma insulin (μLU/mL) | 5.8 ± 0.7 (27, 1.5–12.9) | 6.8 ± 1.1 (30, 1.5–15.7) | 6.3 ± 0.65 | 57 |
| HOMA‐IR | 1.29 ± 0.16 (27, 0.27–2.88) | 1.58 ± 0.30 (30, 0.26–7.94) | 1.4 ± 0.17 | 57 |
| M‐value | 7.1 ± 0.55 (27, 2.22–14.11) | 7.5 ± 0.45 (30, 3.01–14.67) | 7.31 ± 0.35 | 57 |
| Blood cholesterol (mg/dL) | 181.4 ± 8.8 (27, 125–262) | 189.8 ± 6.4 (30, 135–269) | 185.8 ± 5.3 | 57 |
| HDL cholesterol (mg/dL) | 47.7 ± 2.0 (27, 33–71) | 56.1 ± 2.1 (30, 41–80)a | 52.1 ± 1.5 | 57 |
| LDL cholesterol (mg/dL) | 107.7 ± 6.5 (27, 59.8–154) | 111.8 ± 5.6 (30, 72.4–177) | 109.9 ± 4.3 | 57 |
| Blood trigylcerides (mg/dL) | 130.0 ± 17.0 (27, 48–357) | 109.5 ± 8.3 (30, 63–246) | 119.2 ± 9.1 | 57 |
Data are presented mean ± SEM (n, range).
a
P < 0.05 versus men.